Search results for "hepatitis c virus"

showing 10 items of 403 documents

HCV replication in mononuclear cells stimulates anti-HCV-secreting B cells and reflects nonresponsiveness to interferon-α

1995

Recently, it was demonstrated in chronic hepatitis C that the release of IgG and IgM anti-HCV antibodies by mononuclear cells (PBMCs) correlated with inflammatory activity, HCV persistence in serum, and negative outcome from antiviral therapy. Thus, persistent antigenic stimulation of the antibody-secreting B cells has been suggested. In this study, PBMCs were derived from 13 patients with chronic hepatitis C. Nucleic acids were extracted by the guanidine-thiocyanate-method, and plus- and minus-stranded HCV-RNAs were determined using primers from the 5'-untranslated region of HCV. Simultaneously, unstimulated PBMCs were cultured for 8 days and anti-HCV antibodies were detected in the supern…

AdultMaleHepacivirusmedicine.medical_treatmentHepatitis C virusMolecular Sequence DataAlpha interferonHepacivirusInterferon alpha-2Virus Replicationmedicine.disease_causeAntiviral AgentsPeripheral blood mononuclear cellVirusVirologymedicineHumansCells CulturedInterferon alfaAgedDNA PrimersB-LymphocytesBase SequencebiologyInterferon-alphavirus diseasesHepatitis C AntibodiesMiddle Agedbiology.organism_classificationHepatitis CVirologyRecombinant Proteinsdigestive system diseasesTreatment OutcomeInfectious DiseasesCytokineChronic DiseaseImmunologyLeukocytes Mononuclearbiology.proteinRNA ViralFemaleAntibodymedicine.drugJournal of Medical Virology
researchProduct

Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection

2002

Abstract OBJECTIVES: The virological profiles of hepatitis B and C viruses (HBV and HCV) and their interplay in cases of coinfection are undefined. A suppressed and occult HBV infection may occur in hepatitis B surface antigen (HBsAg) negative patients with chronic hepatitis C. The HCV core protein is able to inhibit HBV “in vitro,” and serines at positions 99 and 116 are essential for such inhibition. We aimed to assess the HBV and HCV virological profiles in cases of coinfection and to evaluate the relationship between HCV core gene variability and HBV activity. METHODS: Eighty-two anti-HCV positive patients were examined: 35 cases were HBsAg positive, 24 were HBsAg negative with “occult”…

AdultMaleHepatitis B virusHBsAgHCV RNAHepacivirusHepatitis C virusDUAL INFECTION; INTERFERON THERAPY; HEPATOCELLULAR-CARCINOMA; CHRONIC LIVER-DISEASE; HCV core protein; Hepatitis B Surface Antigens; HCV RNAGenome ViralHepacivirusDUAL INFECTIONVirus Replicationmedicine.disease_causeCHRONIC LIVER-DISEASEHepatitis B ChronicINTERFERON THERAPYOrthohepadnavirusHEPATOCELLULAR-CARCINOMAmedicineHumansAgedHepatitis B virusHepatitis B Surface AntigensHepatologybiologybusiness.industryHCV core proteinGastroenterologyvirus diseasesHepatitis C ChronicMiddle AgedViral LoadHepatitis Bbiology.organism_classificationmedicine.diseaseVirologydigestive system diseasesHepadnaviridaeDNA ViralImmunologyCoinfectionRNA ViralFemalebusinessThe American Journal of Gastroenterology
researchProduct

Occult hepatitis B virus in liver tissue of individuals without hepatic disease

2008

Abstract BACKGROUND/AIMS: While many data are available concerning occult hepatitis B virus (HBV) infection in patients with hepatic disorders, there is little information about this cryptic infection in individuals without liver disease. The aim of this study was to investigate the prevalence of occult HBV in the general population by examining liver specimens from a large series of HBV-surface-antigen negative individuals with no clinical and biochemical evidence of liver disease. METHODS: The presence of HBV DNA was evaluated by testing, through polymerase chain reaction techniques, DNA extracts from 98 liver-disease-free individuals who underwent liver resection or needle biopsy during …

AdultMaleHepatitis B virusHBsAgHepatitis C virusPopulationhepatitis B virus liver tissuemedicine.disease_causeLiver diseaseNormal liverOrthohepadnavirusOccult HBVOccult HBV; HBV DNA; Normal liver; Anti-HBc; HBV-seronegativemedicineHumansHBV-seronegativeHepatitis B AntibodieseducationAgedHepatitis B viruseducation.field_of_studyHepatologybiologybusiness.industryvirus diseasesMiddle AgedHepatitis Bmedicine.diseasebiology.organism_classificationHepatitis B Core AntigensOccultdigestive system diseasesLiverHepadnaviridaeHBV DNACarrier StateDNA ViralImmunologyFemalebusinessAnti-HBcJournal of Hepatology
researchProduct

IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia

1993

SUMMARY To assess the relationship between hepatitis C virus (HCV) infection and essential mixed cryoglobulinaemia (EMC), sera from 23 patients with EMC were tested for IgG and IgM antibodies to HCV antigens and for HCV RNA. Quantitative HCV antibody studies were performed on scrum and purified cryoglobulin fractions. HCV antibodies of both IgG and IgM class were found in 22 (96%) patients. Ten of these were also HCV-RNA positives. Higher litres of anti-HCV IgM were present in the 11 patients with evidence of liver damage. Anti-HCV IgG antibodies were shown to be concentrated in the IgG fraction of cryoglobulins in all eight patients studied. These results strongly suggest a role for HCV in…

AdultMaleHepatitis C virusImmunologyHepacivirusmedicine.disease_causeVirusCryoglobulinsSerologyFlaviviridaeAntigenmedicineHumansImmunology and AllergyHepatitis AntibodiesAgedbiologyvirus diseasesHepatitis C AntibodiesMiddle Agedbiology.organism_classificationHepatitis CVirologydigestive system diseasesCryoglobulinemiaImmunoglobulin MImmunoglobulin GHumoral immunityImmunologybiology.proteinRNA ViralFemaleAntibodyResearch ArticleClinical and Experimental Immunology
researchProduct

Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis

1992

Hepatitis C virus (HCV) replication was assessed before and during alpha-interferon (IFN) treatment in 22 anti-HCV positive patients with posttransfusion or sporadic chronic hepatitis (CH). Eleven patients were “responders” and 11 patients “non-responders” to IFN. Thirteen anti-HCV negative healthy subjects and five anti-HCV negative patients with autoimmune CH served as controls. Serum HCV-RNA was detected by the polymerase chain reaction (PCR) in all untreated anti-HCV positive patients but in none of the anti-HCV negative subjects. PCR primers from the 5′-non-coding (NC) region were more sensitive than primers from a non-structural (NS5) region in detecting HCV-RNA (21/22, 95% vs. 7/22, …

AdultMaleHepatitis C virusMolecular Sequence DataDNA Single-StrandedAlpha interferonHepacivirusAutoimmune hepatitisInterferon alpha-2Virus Replicationmedicine.disease_causePolymerase Chain ReactionSensitivity and SpecificityVirusInterferonVirologymedicineHumansHepatitis AntibodiesViremiaBase Sequencebiologybusiness.industryInterferon-alphavirus diseasesHepatitis C AntibodiesMiddle Agedmedicine.diseaseHepatitis CVirologyRecombinant ProteinsTiterInfectious DiseasesChronic DiseaseImmunologybiology.proteinRNA ViralFemaleViral diseaseAntibodybusinessmedicine.drugJournal of Medical Virology
researchProduct

Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.

2003

To investigate the intra-hepatic activation of the IFN system in patients affected by chronic HCV-infection in comparison with that observed in a non-infectious liver disease such as non-alcoholic steatohepatitis, we measured the liver steady state mRNA levels of interferon-alpha, interferon-beta and interferon-gamma as well as of IFN-related genes (IFNAR-1, STAT1alpha, PKR, 2-5 AS, IRF-1, ICE and IL-18). In HCV-infected subjects, possible correlations of these parameters with viral load and liver injury were also analyzed. Twenty-four chronic untreated HCV-infected subjects and seven patients with non-alcoholic steatohepatitis were enrolled in the study. Liver biopsies were graded accordin…

AdultMaleHepatitis C virusmedicine.medical_treatmentBiopsyHepacivirusReceptor Interferon alpha-betaBiologymedicine.disease_causeVirus ReplicationLiver diseaseVirologyGene expressionmedicineHumansRNA MessengerAgedReceptors InterferonLiver injuryLiver DiseasesInterleukin-18Membrane ProteinsHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseasePhosphoproteinsVirologyDNA-Binding ProteinsInfectious DiseasesCytokineSTAT1 Transcription FactorLiverTrans-ActivatorsFemaleInterferonsSteatohepatitisViral loadInterferon Regulatory Factor-1Journal of medical virology
researchProduct

The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies

1999

Abstract Background/Aims: Cytotoxic T lymphocytes have been demonstrated in peripheral blood and liver tissue of patients with chronic hepatitis C virus infection, but their significance for viral clearance is unknown. Therefore, we analyzed hepatitis C virus-specific cytotoxic T lymphocyte precursor frequencies in chronic hepatitis C virus carriers during interferon-α treatment. Methods: Blood mononuclear cells or CD8+ T cells from HLA-A2 positive and negative patients and controls were analyzed in chromium-release assays using a panel of 18 synthetic peptides from the HCV core, E1 and NS4 antigens bearing HLA-A2 binding motifs. Specific cytotoxic T lymphocyte precursor frequencies were st…

AdultMaleMetabolic Clearance RateHepatitis C virusBiologymedicine.disease_causeAntiviral AgentsAntigenInterferonHLA-A2 AntigenmedicineHumansCytotoxic T cellHepatologyELISPOTInterferon-alphaHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseVirologyTreatment OutcomeCase-Control StudiesImmunologyFemaleViral loadCD8T-Lymphocytes Cytotoxicmedicine.drugJournal of Hepatology
researchProduct

Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors

1994

This study evaluated the performance of third-generation anti-HCV assays in blood donors who were positive by second-generation anti-HCV, and assessed any possible relationship between antibody patterns, HCV replication and liver damage. Fifty-two second-generation enzyme immunoassay-positive asymptomatic Italian blood donors were retested for anti-HCV by third-generation enzyme immunoassay and recombinant immunoblot assay (Ortho third-generation enzyme immunoassay, third-generation recombinant immunoblot assay), utilising recombinant C33c and NS5 and synthetic peptide C100 and C22 antigens, and for HCV-RNA by "nested" polymerase chain reaction with 5' region primers. Alanine aminotransfera…

AdultMaleMicrobiological TechniquesHepatitis C virusImmunoblottingBlood DonorsHepacivirusmedicine.disease_causeVirusSerologylaw.inventionCohort StudiesImmunoenzyme TechniquesAntigenlawmedicineHumansHepatitis AntibodiesPolymerase chain reactionHepatologybiologymedicine.diagnostic_testMiddle AgedVirologyImmunoassaybiology.proteinRecombinant DNARNA ViralFemaleAntibodyJournal of Hepatology
researchProduct

Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines…

2006

ABSTRACTThis study aimed to determine the effect of highly active anti-retroviral therapy (HAART) and hepatitis C virus (HCV) co-infection on peripheral levels of interleukin (IL)-2, IL-10, IL-12 (p70), IL-18 and soluble tumour necrosis factor receptor type II (sTNFRII). Serum levels were monitored for a 1-year period in 25 patients infected with human immunodeficiency virus-1 (HIV-1) who were naive for HAART at the initiation of the study, and in four HIV-1-infected long-term non-progressors. Serum levels of both IL-18 and sTNFRII at baseline were significantly higher in HIV-1-infected patients than in controls. Baseline levels of IL-18 and sTNFRII were not significantly different in long-…

AdultMaleMicrobiology (medical)hepatitis C virusTime FactorsHAARTHepatitis C virusHepacivirusHIV Infectionsmedicine.disease_causeserum cytokinesReceptors Tumor Necrosis FactorVirusEtanerceptAntiretroviral Therapy Highly ActiveImmunopathologymedicineHumansLongitudinal StudiesDemographybiologyhuman immunodeficiency virusbusiness.industryInterleukinsInterleukinvirus diseasesGeneral MedicineHepatitis Csoluble tumour necrosis factor receptor type IIMiddle Agedmedicine.diseasebiology.organism_classificationHepatitis CInfectious DiseasesImmunoglobulin GImmunologyLentivirusHIV-1CytokinesFemaleViral diseasebusinessIL-18Clinical Microbiology and Infection
researchProduct

Risk Factors and Outcome among a Large Patient Cohort with Community-Acquired Acute Hepatitis C in Italy

2006

Background The epidemiology of acute hepatitis C has changed during the past decade in Western countries. Acute HCV infection has a high rate of chronicity, but it is unclear when patients with acute infection should be treated. Methods To evaluate current sources of hepatitis C virus (HCV) transmission in Italy and to assess the rate of and factors associated with chronic infection, we enrolled 214 consecutive patients with newly acquired hepatitis C during 1999-2004. The patients were from 12 health care centers throughout the country, and they were followed up for a mean (+/- SD) period of 14+/-15.8 months. Biochemical liver tests were performed, and HCV RNA levels were monitored. Result…

AdultMaleMicrobiology (medical)medicine.medical_specialtyHepatitis C virusHepacivirus.medicine.disease_causeAsymptomaticMED/17 Malattie infettiveRisk FactorsInternal medicineEpidemiologyHumansMedicineRisk factorHepatitisbusiness.industryTransmission (medicine)Hepatitis CMiddle Agedmedicine.diseaseHepatitis CCommunity-Acquired InfectionsChronic infectionInfectious DiseasesItalyAcute DiseaseImmunologyFemalemedicine.symptombusinessClinical Infectious Diseases
researchProduct